Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02809859 · ClinicalTrials.gov registry record · NA

CPAP In-home Assessment USA

A NA study, sponsored by Fisher and Paykel Healthcare.

Completed
Registry status
NA
Development phase
139
Enrollment target

NCT02809859 is a NA study that has completed, run by Fisher and Paykel Healthcare. The registered enrollment target is 139 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02809859, a NA study, has completed, sponsored by Fisher and Paykel Healthcare.

COMPLETED
Registry status
NA
Development phase
139 participants
Enrollment target

Study Summary

The study is to evaluate the product reliability, therapy effectiveness and user feedback of a Continuous Positive Airway Pressure (CPAP) device in-home for up to 6 months.

Interventions

  • DEVICE Fisher & Paykel Healthcare CPAP Device

Trial Details

FieldValue
Enrollment Target 139 participants
Start Date 2016-07
Est. Completion 2017-04
Phase NA

Sponsor

Fisher and Paykel Healthcare

25 total trials

What the Registry Record Tells You About NCT02809859

The ClinicalTrials.gov registry entry for NCT02809859 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fisher and Paykel Healthcare, which has 25 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Fisher & Paykel Healthcare CPAP Device is the first listed.

NCT02809859 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02809859 about?

NCT02809859 is a clinical study titled "CPAP In-home Assessment USA". The study is to evaluate the product reliability, therapy effectiveness and user feedback of a Continuous Positive Airway Pressure (CPAP) device in-home for up to 6 months.

What is the current status of trial NCT02809859?

This trial is currently completed. It is a NA study. The enrollment target is 139 participants. The study started on 2016-07. Estimated completion is 2017-04.

What interventions are being tested in trial NCT02809859?

The interventions under investigation include: Fisher & Paykel Healthcare CPAP Device (DEVICE).

Who is sponsoring clinical trial NCT02809859?

This trial is sponsored by Fisher and Paykel Healthcare, which has 25 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.